These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29030011)

  • 21. Molecular biology of Pasteurella multocida toxin.
    Orth JH; Aktories K
    Curr Top Microbiol Immunol; 2012; 361():73-92. PubMed ID: 22371145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Pasteurella multocida toxin on the osteoclast population of the rat.
    Martineau-Doizé B; Caya I; Gagné S; Jutras I; Dumas G
    J Comp Pathol; 1993 Jan; 108(1):81-91. PubMed ID: 8473561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
    Kim TJ; Lee JI; Lee BJ
    J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
    Seo J; Lee S; Pyo H; Lee J; Kim T
    Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of osteoclast-like cell formation by Pasteurella multocida toxin from hemopoietic progenitor cells in mouse bone marrow cultures.
    Jutras I; Martineau-Doizé B
    Can J Vet Res; 1996 Jan; 60(1):34-9. PubMed ID: 8825991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of heterotrimeric G-proteins in Swiss 3T3 cells stimulated with Pasteurella multocida toxin.
    Babb RC; Homer KA; Robbins J; Lax AJ
    PLoS One; 2012; 7(11):e47188. PubMed ID: 23144805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the humoral immune response of swine and mice mediated by toxigenic Pasteurella multocida.
    Jordan RW; Hamilton TD; Hayes CM; Patel D; Jones PH; Roe JM; Williams NA
    FEMS Immunol Med Microbiol; 2003 Oct; 39(1):51-9. PubMed ID: 14556996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pasteurella multocida toxin: Targeting mast cell secretory granules during kiss-and-run secretion.
    Danielsen EM; Christiansen N; Danielsen EM
    Tissue Cell; 2016 Feb; 48(1):1-9. PubMed ID: 26763205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate specificity of Pasteurella multocida toxin for α subunits of heterotrimeric G proteins.
    Orth JH; Fester I; Siegert P; Weise M; Lanner U; Kamitani S; Tachibana T; Wilson BA; Schlosser A; Horiguchi Y; Aktories K
    FASEB J; 2013 Feb; 27(2):832-42. PubMed ID: 23150526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atrophic rhinitis of swine: neutralization of the toxin of Pasteurella multocida].
    Schimmelpfennig H
    Dtsch Tierarztl Wochenschr; 1990 May; 97(5):195-6. PubMed ID: 2364889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gα
    Chakraborty S; Handrick B; Yu D; Bode KA; Hafner A; Schenz J; Schaack D; Uhle F; Tachibana T; Kamitani S; Vogl T; Kubatzky KF
    Front Cell Infect Microbiol; 2022; 12():1016299. PubMed ID: 36699722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative.
    Nielsen JP; Foged NT; Sørensen V; Barfod K; Bording A; Petersen SK
    Can J Vet Res; 1991 Apr; 55(2):128-38. PubMed ID: 1832079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.
    Wilson BA; Ho M
    FEBS J; 2011 Dec; 278(23):4616-32. PubMed ID: 21569202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling cascades of Pasteurella multocida toxin in immune evasion.
    Kubatzky KF; Kloos B; Hildebrand D
    Toxins (Basel); 2013 Sep; 5(9):1664-81. PubMed ID: 24064721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs.
    To H; Someno S; Nagai S
    Am J Vet Res; 2005 Jan; 66(1):113-8. PubMed ID: 15691045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of Galpha (i) and subsequent uncoupling of receptor-Galpha(i) signaling by Pasteurella multocida toxin.
    Orth JH; Fester I; Preuss I; Agnoletto L; Wilson BA; Aktories K
    J Biol Chem; 2008 Aug; 283(34):23288-94. PubMed ID: 18583341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
    Suckow MA
    Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pasteurella multocida toxin stimulates bone resorption by osteoclasts via interaction with osteoblasts.
    Mullan PB; Lax AJ
    Calcif Tissue Int; 1998 Oct; 63(4):340-5. PubMed ID: 9744994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.
    Rutter JM
    Res Vet Sci; 1983 May; 34(3):287-95. PubMed ID: 6878879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.